NCT05505682

Brief Summary

The study is a cluster-randomised controlled trial set in Singapore, to assess if the deployment of male Wolbachia-infected Aedes aegypti mosquitoes can reduce dengue incidence in intervention clusters.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
724,428

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 19, 2022

Completed
9 days until next milestone

Study Start

First participant enrolled

July 28, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

August 18, 2022

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 13, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 13, 2024

Completed
Last Updated

May 22, 2025

Status Verified

May 1, 2025

Enrollment Period

2.1 years

First QC Date

July 19, 2022

Last Update Submit

May 19, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Odds ratio of Wolbachia exposure distribution among laboratory-confirmed reported dengue cases compared to test-negative controls

    Dengue cases and dengue test-negative controls data will be obtained from the national surveillance network of diagnostic laboratories which receive samples for dengue testing.

    Up to 3 years

  • Laboratory-confirmed reported dengue case counts normalized by population size in intervention versus non-intervention clusters

    Dengue cases data will be obtained from the national surveillance network of diagnostic laboratories which receive samples for dengue testing.

    Up to 3 years

Secondary Outcomes (2)

  • Prevalence of Ae. aegypti/Ae. albopictus mosquitoes

    Up to 3 years

  • Public Attitudes, Perceptions & Knowledge (APK) of Wolbachia and other vector control interventions

    Up to 3 years

Study Arms (2)

Intervention clusters

EXPERIMENTAL

Residential areas that receive releases of male Wolbachia-infected Aedes aegypti

Biological: Biological (Male Wolbachia-infected Aedes aegypti)

Non-intervention clusters

NO INTERVENTION

Residential areas that do not receive releases of male Wolbachia-infected Aedes aegypti

Interventions

Releases of male Wolbachia-infected Aedes aegypti mosquitoes

Intervention clusters

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Dengue-suspected patients living in the intervention and non-intervention clusters whose blood samples are collected by a national network of diagnostic laboratories that support private clinics, public polyclinics, or public/private hospitals.
  • Test positive cases: Patients with virologically confirmed DENV infection through RT-qPCR, testing positive for NS1 antigen or IgM. A positive test for any of the three assays would classify the patient as a dengue case.
  • Test negative controls: Patients with negative test results for DENV through RT-qPCR, NS1 antigen ELISA, or DENV IgM.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Environment Agency

Singapore, Singapore

Location

Related Publications (4)

  • Anders KL, Indriani C, Ahmad RA, Tantowijoyo W, Arguni E, Andari B, Jewell NP, Rances E, O'Neill SL, Simmons CP, Utarini A. The AWED trial (Applying Wolbachia to Eliminate Dengue) to assess the efficacy of Wolbachia-infected mosquito deployments to reduce dengue incidence in Yogyakarta, Indonesia: study protocol for a cluster randomised controlled trial. Trials. 2018 May 31;19(1):302. doi: 10.1186/s13063-018-2670-z.

    PMID: 29855331BACKGROUND
  • Utarini A, Indriani C, Ahmad RA, Tantowijoyo W, Arguni E, Ansari MR, Supriyati E, Wardana DS, Meitika Y, Ernesia I, Nurhayati I, Prabowo E, Andari B, Green BR, Hodgson L, Cutcher Z, Rances E, Ryan PA, O'Neill SL, Dufault SM, Tanamas SK, Jewell NP, Anders KL, Simmons CP; AWED Study Group. Efficacy of Wolbachia-Infected Mosquito Deployments for the Control of Dengue. N Engl J Med. 2021 Jun 10;384(23):2177-2186. doi: 10.1056/NEJMoa2030243.

    PMID: 34107180BACKGROUND
  • Lim JT, Mailepessov D, Chong CS, Chang CC, Dickens B, Lai YL, Deng L, Lee C, Tan LY, Chain G, Ho SH, Zulkifli MF, Liew J, Vasquez K, Lee V, Wong JCC, Sim S, Tan CH, Ng LC. Update to: Assessing the efficacy of male Wolbachia-infected mosquito deployments to reduce dengue incidence in Singapore. Trials. 2024 Jun 20;25(1):400. doi: 10.1186/s13063-024-08148-z.

  • Ong J, Ho SH, Soh SXH, Wong Y, Ng Y, Vasquez K, Lai YL, Setoh YX, Chong CS, Lee V, Wong JCC, Tan CH, Sim S, Ng LC, Lim JT. Assessing the efficacy of male Wolbachia-infected mosquito deployments to reduce dengue incidence in Singapore: study protocol for a cluster-randomized controlled trial. Trials. 2022 Dec 17;23(1):1023. doi: 10.1186/s13063-022-06976-5.

MeSH Terms

Conditions

Dengue

Interventions

Biological Products

Condition Hierarchy (Ancestors)

Mosquito-Borne DiseasesVector Borne DiseasesInfectionsArbovirus InfectionsVirus DiseasesFlavivirus InfectionsFlaviviridae InfectionsRNA Virus InfectionsHemorrhagic Fevers, Viral

Intervention Hierarchy (Ancestors)

Complex Mixtures

Study Officials

  • Lee Ching Ng, PhD

    Group Director (Environmental Health Institute)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Parallel, two-arm, non-blinded cluster-randomised controlled trial
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Group Director (Environmental Health Institute)

Study Record Dates

First Submitted

July 19, 2022

First Posted

August 18, 2022

Study Start

July 28, 2022

Primary Completion

September 13, 2024

Study Completion

September 13, 2024

Last Updated

May 22, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations